This Article Full Text Full Text (PDF) All Versions of this Article: 144/10/4280    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, W. Articles by Ilio, K. Search for Related Content PubMed PubMed Citation Articles by Zhou, W. Articles by Ilio, K.

Dual Regulation of Proliferation and Growth Arrest in Prostatic Stromal Cells by Transforming Growth Factor-ß1

Departments of Urology (W.Z., I.P., J.M.K., C.L., K.I.), Pathology (M.P.), and Preventive Medicine (B.J.), Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611; and Institute of Molecular Biology (J.Z.), Nankai University, Tainjing 300071, China

Address all correspondence and requests for reprints to: Dr. Chung Lee, Department of Urology, Tarry 16-733, 303 East Chicago Avenue, Chicago, Illinois 60611.

Abstract

In a preliminary study, we observed that TGF-ß1 induced both proliferation and growth arrest in prostatic stromal cells, depending on the concentration of TGF-ß1 used in the culture medium. In this study, we explored possible mechanisms of this dual effect of TGF-ß. Primary cultures of prostatic stromal cells, established from clinical surgical specimens and treated with low doses of TGF-ß1 (0.001–0.01 ng/ml), resulted in an increase in cell proliferation. The addition of neutralizing antibody against platelet-derived growth factor (PDGF)-BB, but not anti-PDGF-AA, abrogated this stimulatory effect of TGF-ß1. TGF-ß1 treatment resulted in a dose-related increase in PDGF-BB production as measured by ELISA. Cells underwent growth arrest at high concentrations of TGF-ß1 (1.0 and 10 ng/ml). An inhibitor of cyclin-dependent kinase (cdk), p15^INK4b, was up-regulated at both transcript and protein levels in these cultures by TGF-ß1 in a dose-related manner as determined by RT-PCR and Western blot analysis. The transcript, but not the protein, for another cdk inhibitor, p21^Cip1, was up-regulated with treatment of TGF-ß1 to these cells. Levels of other cdk inhibitors, such as p16^INK4a and p27^Kip1, were constitutively expressed in prostatic stromal cells and were not significantly affected by TGF-ß1 treatment. Finally, the growth arrest effect of TGF-ß1 was abrogated when antisense oligonucleotides to p15^INH4b, but not p21^Cip1, were added to the culture medium. These data indicate that the dual effect of TGF-ß1 is mediated, at least, by up-regulation of PDGF-BB and p15^INK4b, respectively.

This article has been cited by other articles:

				W. Li, C.-L. Wu, P. G. Febbo, and A. F. Olumi Stromally Expressed c-Jun Regulates Proliferation of Prostate Epithelial Cells Am. J. Pathol., October 1, 2007; 171(4): 1189 - 1198. [Abstract] [Full Text] [PDF]

				G. T. Lee, J. H. Hong, C. Kwak, J. Woo, V. Liu, C. Lee, and I. Y. Kim Effect of Dominant Negative Transforming Growth Factor-{beta} Receptor Type II on Cytotoxic Activity of RAW 264.7, a Murine Macrophage Cell Line Cancer Res., July 15, 2007; 67(14): 6717 - 6724. [Abstract] [Full Text] [PDF]

				Q. Zhang, J. N. Rubenstein, T. L. Jang, M. Pins, B. Javonovic, X. Yang, S.-J. Kim, I. Park, and C. Lee Insensitivity to Transforming Growth Factor-{beta} Results from Promoter Methylation of Cognate Receptors in Human Prostate Cancer Cells (LNCaP) Mol. Endocrinol., September 1, 2005; 19(9): 2390 - 2399. [Abstract] [Full Text] [PDF]

				D. C. Tomlinson, S. H. Freestone, O. C. Grace, and A. A. Thomson Differential Effects of Transforming Growth Factor-{beta}1 on Cellular Proliferation in the Developing Prostate Endocrinology, September 1, 2004; 145(9): 4292 - 4300. [Abstract] [Full Text] [PDF]